Clinical Trial Update: Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris [EARLY_Phase 1]

View source ↗

Summary

Clinical trial evaluating 0.5% timolol eye drops for post-inflammatory erythema after acne vulgaris. The study is in early phase 1 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Post-inflammatory Erythema

Drugs mentioned

• Timolol 0.5% Eye Drops (timolol)

Snippet

Sponsor: Pham Ngoc Thach University of Medicine | Conditions: Post Inflammtory Erythema, Acne Vulgaris | EARLY_Phase 1 | Status: RECRUITING